These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 23296943)

  • 1. Application of a new human cell line, F2N78, in the transient and stable production of recombinant therapeutics.
    Lee HJ; Chang M; Kim JM; Hong H; Maeng K; Koo J; Chang S; Cho MS
    Biotechnol Prog; 2013; 29(2):432-40. PubMed ID: 23296943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and applications of epstein-barr virus-based episomal vectors in human embryonic stem cells.
    Ren C; Zhao M; Yang X; Li D; Jiang X; Wang L; Shan W; Yang H; Zhou L; Zhou W; Zhang H
    Stem Cells; 2006 May; 24(5):1338-47. PubMed ID: 16410388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-scale transient transfection of serum-free suspension-growing HEK293 EBNA1 cells: peptone additives improve cell growth and transfection efficiency.
    Pham PL; Perret S; Doan HC; Cass B; St-Laurent G; Kamen A; Durocher Y
    Biotechnol Bioeng; 2003 Nov; 84(3):332-42. PubMed ID: 12968287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
    J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells.
    Durocher Y; Perret S; Kamen A
    Nucleic Acids Res; 2002 Jan; 30(2):E9. PubMed ID: 11788735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribosome Protein L4 is essential for Epstein-Barr Virus Nuclear Antigen 1 function.
    Shen CL; Liu CD; You RI; Ching YH; Liang J; Ke L; Chen YL; Chen HC; Hsu HJ; Liou JW; Kieff E; Peng CW
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2229-34. PubMed ID: 26858444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioreactor-scale production and one-step purification of Epstein-Barr nuclear antigen 1 expressed in baculovirus-infected insect cells.
    Meij P; Vervoort MB; de Gooijer K; Bloemena E; Meijer CJ; Middeldorp JM
    Protein Expr Purif; 2000 Nov; 20(2):324-33. PubMed ID: 11049756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of VCA (viral capsid antigen) and EBNA1 (Epstein-Barr-virus-encoded nuclear antigen 1) genes of Epstein-Barr virus in Pichia pastoris and application of the products in a screening test for patients with nasopharyngeal carcinoma.
    Hu B; Hong G; Li Z; Xu J; Zhu Z; Li L
    Biotechnol Appl Biochem; 2007 May; 47(Pt 1):59-69. PubMed ID: 17129209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA ligand designed to antagonize EBNA1 represses Epstein-Barr virus-induced immortalization.
    Yasuda A; Noguchi K; Minoshima M; Kashiwazaki G; Kanda T; Katayama K; Mitsuhashi J; Bando T; Sugiyama H; Sugimoto Y
    Cancer Sci; 2011 Dec; 102(12):2221-30. PubMed ID: 21910783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatin-binding regions of EBNA1 protein facilitate the enhanced transfection of Epstein-Barr virus-based vectors.
    Howden SE; Wardan H; Voullaire L; McLenachan S; Williamson R; Ioannou P; Vadolas J
    Hum Gene Ther; 2006 Aug; 17(8):833-44. PubMed ID: 16942443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration.
    Murakami M; Lan K; Subramanian C; Robertson ES
    J Virol; 2005 Feb; 79(3):1559-68. PubMed ID: 15650182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.
    Deakyne JS; Malecka KA; Messick TE; Lieberman PM
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high-yielding CHO transient system: coexpression of genes encoding EBNA-1 and GS enhances transient protein expression.
    Daramola O; Stevenson J; Dean G; Hatton D; Pettman G; Holmes W; Field R
    Biotechnol Prog; 2014; 30(1):132-41. PubMed ID: 24106171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers.
    Daskalogianni C; Pyndiah S; Apcher S; Mazars A; Manoury B; Ammari N; Nylander K; Voisset C; Blondel M; Fåhraeus R
    J Pathol; 2015 Jan; 235(2):334-41. PubMed ID: 25186125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Epstein-Barr virus EBNA1 protein in Escherichia coli: purification under nondenaturing conditions and use in DNA-binding studies.
    Bouallag N; Gaillard C; Maréchal V; Strauss F
    Protein Expr Purif; 2009 Sep; 67(1):35-40. PubMed ID: 19393319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The V-val subtype Epstein-Barr virus nuclear antigen 1 promotes cell survival after serum withdrawal.
    Chao M; Wang HN; Lu YJ; Chang YS; Yu JS
    Oncol Rep; 2015 Feb; 33(2):958-66. PubMed ID: 25434292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells.
    Mũcke S; Polack A; Pawlita M; Zehnpfennig D; Massoudi N; Bohlen H; Doerfler W; Bornkamm G; Diehl V; Wolf J
    Gene Ther; 1997 Feb; 4(2):82-92. PubMed ID: 9081710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus.
    Dheekollu J; Wiedmer A; Sentana-Lledo D; Cassel J; Messick T; Lieberman PM
    J Virol; 2016 Jun; 90(11):5353-5367. PubMed ID: 27009953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells.
    Hong M; Murai Y; Kutsuna T; Takahashi H; Nomoto K; Cheng CM; Ishizawa S; Zhao QL; Ogawa R; Harmon BV; Tsuneyama K; Takano Y
    J Cancer Res Clin Oncol; 2006 Jan; 132(1):1-8. PubMed ID: 16180023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. siRNAs against the Epstein Barr virus latency replication factor, EBNA1, inhibit its function and growth of EBV-dependent tumor cells.
    Yin Q; Flemington EK
    Virology; 2006 Mar; 346(2):385-93. PubMed ID: 16343579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.